ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,225Medicare Part D Prescriptions Filled, Including Refills

Rank: 411 out of 3734

$623K Total Retail Price of All Prescriptions

Rank: 435 out of 3734

464 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 464 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

3% of this provider’s 464 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

0% of this provider’s 10,983 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
FUROSEMIDE 560 560 1 7
SIMVASTATIN 441 440 2 1
LEVOTHYROXINE SODIUM 374 373 3 2
METOPROLOL TARTRATE 341 336 4 6
WARFARIN SODIUM 334 327 5 10
DONEPEZIL HCL 312 312 6 25
AMLODIPINE BESYLATE 309 309 7 5
LISINOPRIL 266 263 8 3
OMEPRAZOLE 264 261 9 4
MIRTAZAPINE 254 253 10 45
NAMENDA 228 228 11 44
HYDROCHLOROTHIAZIDE 211 208 12 9
PANTOPRAZOLE SODIUM 206 196 13 22
POTASSIUM CHLORIDE 196 195 14 19
SERTRALINE HCL 189 189 15 18
METOPROLOL SUCCINATE 184 184 16 14
GABAPENTIN 161 161 17 17
TRAMADOL HCL 155 155 18 20
CITALOPRAM HBR 121 120 19 16
ATORVASTATIN CALCIUM 117 114 20 11
POLYETHYLENE GLYCOL 3350 106 106 21 53
CYMBALTA 103 103 22 67
CLOPIDOGREL 100 100 23 23
DIGOXIN 100 96 23 43
RAMIPRIL 95 95 25 91
LOSARTAN POTASSIUM 94 94 26 21
FAMOTIDINE 93 93 27 60
TRAZODONE HCL 90 84 28 49
ATENOLOL 86 86 29 13
TAMSULOSIN HCL 79 75 30 29
DIOVAN 74 74 31 31
LATANOPROST 71 71 32 197
METFORMIN HCL 70 67 33 8
FINASTERIDE 68 68 34 88
PLAVIX 67 67 35 39
LANTUS 66 66 36 54
JANTOVEN 65 65 37 76
ALENDRONATE SODIUM 64 64 38 26
QUETIAPINE FUMARATE 64 64 38 82
TRAMADOL HCL-ACETAMINOPHEN 63 62 40 191
ESCITALOPRAM OXALATE 60 54 41 68
PRAVASTATIN SODIUM 59 59 42 15
EVISTA 58 58 43 130
AMIODARONE HCL 57 57 44 203
LEVOFLOXACIN 57 56 44 116
NIFEDIPINE ER 56 56 46 113
MIDODRINE HCL 54 54 47 375
GLIPIZIDE 53 53 48 57
PREDNISONE 51 48 49 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.